First efficacy results of a 2-stage Simon's design randomised phase 2 of darolutamide or capecitabine in patients with triplenegative, androgen receptor positive advanced breast cancer (UCBG06-3)
CANCER RESEARCH(2021)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined